Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Medicamen Biotech Ltd (MEBI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
539.10 -19.90    -3.56%
03/05 - Closed. Currency in INR ( Disclaimer )
  • Volume: 8,719
  • Bid/Ask: 534.40 / 543.55
  • Day's Range: 531.05 - 567.00
Type:  Equity
Market:  India
ISIN:  INE646B01010 
S/N:  MEDICAMEQ
Medicamen Biotech 539.10 -19.90 -3.56%

Medicamen Biotech Ltd Company Profile

 
Get an in-depth profile of Medicamen Biotech Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

357

Equity Type

ORD

Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company’s products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.

Contact Information

Address 1506, Chiranjiv Tower 43, Nehru Place
New Delhi, 110019
India
Phone 91 11 4758 9500
Fax 91 11 2621 3081

Top Executives

Name Age Since Title
Ravi Kumar Bansal 58 2019 Independent Non-Executive Director
Suresh Kumar Singh 76 2015 Non-Executive Non-Independent Director
Sumita Dwivedi 51 2018 Independent Non-Executive Woman Director
Ashwani Kumar Sharma 62 2015 Non-Executive Non-Independent Director
Harish Pande 67 2015 Independent Non-Executive Director
Arun Kumar 81 2016 Independent Non-Executive Director
Sangeeta Bishnoi 51 2019 Independent Non-Executive Woman Director
Vimal Kumar Shrawat 59 2019 Non-Executive Non-Independent Director
Sanjay Bansal 57 2016 Non-Executive Non-Independent Director
Rahul Bishnoi 59 2015 Non-Executive Chairman
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MEBI Comments

Write your thoughts about Medicamen Biotech Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email